ZOLGENSMA INTRATHECAL Trademark

Trademark Overview


On Tuesday, April 1, 2025, a trademark application was filed for ZOLGENSMA INTRATHECAL with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA INTRATHECAL trademark a serial number of 99114521. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 10, 2025. This trademark is owned by Novartis AG. The ZOLGENSMA INTRATHECAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials, sold as a unit, for sustained survival motor neuron protein expression being for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis
zolgensma intrathecal

General Information


Serial Number99114521
Word MarkZOLGENSMA INTRATHECAL
Filing DateTuesday, April 1, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials, sold as a unit, for sustained survival motor neuron protein expression being for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis
NOT AVAILABLE"INTRATHECAL"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 1, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressBasel 4002
CH

Trademark Events


Event DateEvent Description
Tuesday, April 1, 2025NEW APPLICATION ENTERED
Tuesday, April 1, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 1, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, April 30, 2025ASSIGNED TO EXAMINER
Tuesday, May 6, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 6, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 6, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, May 6, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, May 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 4, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 10, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 10, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED